500009 Stock Overview
Ambalal Sarabhai Enterprises Limited, together with its subsidiaries, manufactures, markets, and supplies pharmaceutical products in India and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Ambalal Sarabhai Enterprises Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹47.51 |
| 52 Week High | ₹70.00 |
| 52 Week Low | ₹20.90 |
| Beta | 0.20 |
| 1 Month Change | 0.78% |
| 3 Month Change | -10.38% |
| 1 Year Change | 120.57% |
| 3 Year Change | 101.74% |
| 5 Year Change | 232.94% |
| Change since IPO | 228.79% |
Recent News & Updates
Recent updates
Shareholder Returns
| 500009 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -0.2% | -0.5% | 1.4% |
| 1Y | 120.6% | 55.3% | 46.1% |
Return vs Industry: 500009 exceeded the Indian Pharmaceuticals industry which returned 55.3% over the past year.
Return vs Market: 500009 exceeded the Indian Market which returned 46.1% over the past year.
Price Volatility
| 500009 volatility | |
|---|---|
| 500009 Average Weekly Movement | 8.8% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.8% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 500009's share price has been volatile over the past 3 months.
Volatility Over Time: 500009's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1880 | n/a | Mohal Sarabhai | ase.life |
Ambalal Sarabhai Enterprises Limited, together with its subsidiaries, manufactures, markets, and supplies pharmaceutical products in India and internationally. The company operates through Pharmaceuticals and Electronics segments. It offers products for oncology, infertility, and uro-gynaec areas under the Sarabhai house name; generic and veterinary products; antifungal active ingredient products; vitamin C coated products; and analytical, test, and measuring instruments, as well as supplies finished dosage forms and active pharmaceutical ingredients.
Ambalal Sarabhai Enterprises Limited Fundamentals Summary
| 500009 fundamental statistics | |
|---|---|
| Market cap | ₹3.64b |
| Earnings (TTM) | ₹28.86m |
| Revenue (TTM) | ₹1.65b |
126.2x
P/E Ratio2.2x
P/S RatioIs 500009 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 500009 income statement (TTM) | |
|---|---|
| Revenue | ₹1.65b |
| Cost of Revenue | ₹968.95m |
| Gross Profit | ₹685.73m |
| Other Expenses | ₹656.88m |
| Earnings | ₹28.86m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.38 |
| Gross Margin | 41.44% |
| Net Profit Margin | 1.74% |
| Debt/Equity Ratio | 35.0% |
How did 500009 perform over the long term?
See historical performance and comparison